Here we describe the development of an addressable fractionation-PRM platform, which provides measurements of PD-1, PD-L1, and PD-L2 at femtomole per microgram tissue protein levels in FFPE sections of human melanoma biopsies. Here, PDCD1 is linked to melanoma.